Results strongly support continued development of Cytoki's oral IL-22 program for UC which is part of its growing preclinical pipeline of IL-22-based assets SØBORG, Denmark, May 8, 2025 /PRNewswire/ - ...
Inflammatory bowel disease, in which the immune system attacks the gut, is a painful chronic condition that affects three million Americans. Rates of IBD are rising, and there’s currently no cure. IBD ...
Inflammatory bowel disease (IBD) belongs to a broader category of health conditions known as immune-mediated inflammatory diseases (IMIDs). These disorders share a common characteristic: chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results